Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | Senior VP- International | May 11, 2017 | May 18, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Prestige Consumer Healthcare Inc.
Report date May 11, 2017 · Filed May 18, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 62,075 |
Ending reported balance
After 2017-05-12 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-05-11 · Tax withholding · Disposed 1,175 · Balance 65,122 Row 2 · 2017-05-12 · Tax withholding · Disposed 1,567 · Balance 63,555 Row 3 · 2017-05-12 · Tax withholding · Disposed 1,480 · Balance 62,075 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2017 Filed May 18, 2017 16:10 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 1,480 | $52.22 | $77,285.60 |
DisclosureSEC source: 0001144204-17-028405 · v467391_form4.xml · nonDerivative · entry 3 Parkinson John · CIK 0001405089 · Senior VP- International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,075 Read SEC document |
| May 12, 2017 Filed May 18, 2017 16:10 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 1,567 | $52.22 | $81,828.74 |
DisclosureSEC source: 0001144204-17-028405 · v467391_form4.xml · nonDerivative · entry 2 Parkinson John · CIK 0001405089 · Senior VP- International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,555 Read SEC document |
| May 11, 2017 Filed May 18, 2017 16:10 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 1,175 | $53.54 | $62,909.50 |
DisclosureSEC source: 0001144204-17-028405 · v467391_form4.xml · nonDerivative · entry 1 Parkinson John · CIK 0001405089 · Senior VP- International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,122 Read SEC document |
| May 08, 2017 Filed May 16, 2017 18:04 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 5,429 | $0.00 Strike: $56.11 | $0.00 |
DisclosureSEC source: 0001144204-17-028020 · v467221_4.xml · derivative · entry 2 Parkinson John · CIK 0001405089 · Senior VP- Internationa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,429 Underlying: Common Stock · 5,429 shares Expires 2027-05-08 F2 · derivative.exercise_date: The options vest in three installments as follows: 1,809 shares on May 8, 2018 and 1,810 shares each on 2019 and 2020. Read SEC document |
| May 08, 2017 Filed May 16, 2017 18:04 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 2,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-028020 · v467221_4.xml · nonDerivative · entry 1 Parkinson John · CIK 0001405089 · Senior VP- Internationa 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,297 F1 · shares: The restricted stock units vest in three installments as follows: 696 shares each on May 8, 2018, 2019 and 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.